22.2001 -0.08 (-0.36%) | 03-28 15:25 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 26.25 | 1-year : | 26.88 |
Resists | First : | 22.48 | Second : | 23.02 |
Pivot price | 22.05 | |||
Supports | First : | 21.61 | Second : | 17.97 |
MAs | MA(5) : | 22.04 | MA(20) : | 22.12 |
MA(100) : | 21.29 | MA(250) : | 20.78 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 55.3 | D(3) : | 44.3 |
RSI | RSI(14): 51.7 | |||
52-week | High : | 23.02 | Low : | 18.18 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IBBQ ] has closed below upper band by 34.8%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 22.3 - 22.39 | 22.39 - 22.48 |
Low: | 21.76 - 21.86 | 21.86 - 21.96 |
Close: | 22.11 - 22.26 | 22.26 - 22.43 |
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Thu, 14 Mar 2024
Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update - Defense World
Tue, 12 Mar 2024
Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Stock Price Down 0.2% - Defense World
Tue, 05 Mar 2024
Biotech Rally in Its Early Innings - ETF Trends
Mon, 04 Mar 2024
6 Factors to Bet on Wall Street: ETFs to Buy - Yahoo Finance
Thu, 29 Feb 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
Tue, 09 Jan 2024
Biotech ETFs Stage Solid Comeback at the Start of 2024 - Zacks Investment Research
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Real Estate
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |